The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Is It Reliable to Take the Molecular Docking Top Scoring Position as the Best Solution without Considering Available Structural Data?
Open accessAbstract
Molecular docking is the most frequently used computational method for studying the interactions between organic molecules and biological macromolecules. In this context, docking allows predicting the preferred pose of a ligand inside a receptor binding site. However, the selection of the “best” solution is not a trivial task, despite the widely accepted selection criterion that the best pose corresponds to the best energy score. Here, several rigid-target docking methods were evaluated on the same dataset with respect to their ability to reproduce crystallographic binding orientations, to test if the best energy score is a reliable criterion for selecting the best solution. For this, two experiments were performed: (A) to reconstruct the ligand-receptor complex by performing docking of the ligand in its own crystal structure receptor (defined as self-docking), and (B) to reconstruct the ligand-receptor complex by performing docking of the ligand in a crystal structure receptor that contains other ligand (defined as cross-docking). Root-mean square deviation (RMSD) was used to evaluate how different the obtained docking orientation is from the corresponding co-crystallized pose of the same ligand molecule. We found that docking score function is capable of predicting crystallographic binding orientations, but the best ranked solution according to the docking energy is not always the pose that reproduces the experimental binding orientation. This happened when self-docking was achieved, but it was critical in cross-docking. Taking into account that docking is typically used with predictive purposes, during cross-docking experiments, our results indicate that the best energy score is not a reliable criterion to select the best solution in common docking applications. It is strongly recommended to choose the best docking solution according to the scoring function along with additional structural criteria described for analogue ligands to assure the selection of a correct docking solution.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009) · Journal of Computational Chemistry · doi:10.1002/jcc.21256 · Cited by 25,486
Jorgensen, W. L., Maxwell, D. S., & Tirado-Rives, J. (1996) · Journal of the American Chemical Society · doi:10.1021/ja9621760 · Cited by 15,409
Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., Repasky, M. P., Knoll, E. H., Shelley, M., Perry, J. K., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0306430 · Cited by 10,057
Friesner, R. A., Murphy, R. B., Repasky, M. P., Frye, L. L., Greenwood, J. R., Halgren, T. A., Sanschagrin, P. C., & Mainz, D. T. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051256o · Cited by 6,851
Halgren, T. A., Murphy, R. B., Friesner, R. A., Beard, H. S., Frye, L. L., Pollard, W. T., & Banks, J. L. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030644s · Cited by 5,177
Docking and scoring in virtual screening for drug discovery: methods and applications
Kitchen, D. B., Decornez, H., Furr, J. R., & Bajorath, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1549 · Cited by 4,150
Kaminski, G. A., Friesner, R. A., Tirado-Rives, J., & Jorgensen, W. L. (2001) · The Journal of Physical Chemistry B · doi:10.1021/jp003919d · Cited by 4,060
Molecular Docking: A Powerful Approach for Structure-Based Drug Discovery
Meng, X.-Y., Zhang, H.-X., Mezei, M., & Cui, M. (2011) · Current Computer Aided-Drug Design · doi:10.2174/157340911795677602 · Cited by 3,771
A semiempirical free energy force field with charge‐based desolvation
Huey, R., Morris, G. M., Olson, A. J., & Goodsell, D. S. (2007) · Journal of Computational Chemistry · doi:10.1002/jcc.20634 · Cited by 2,246 · cited 1×
“AutoDock uses a semi-empirical free energy force field to predict binding energies or ligands to macromolecular targets and Lamarckian genetic algorithm (GA) to search for docking solutions [69].”
MethodEldridge, M. D., Murray, C. W., Auton, T. R., Paolini, G. V., & Mee, R. P. (1997) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1007996124545 · Cited by 1,686
Automated docking of flexible ligands: Applications of autodock
Goodsell, D. S., Morris, G. M., & Olson, A. J. (1996) · Journal of Molecular Recognition · doi:10.1002/(sici)1099-1352(199601)9:1<1::aid-jmr241>3.0.co;2-6 · Cited by 1,582
Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity
Tsai, J., Lee, J. T., Wang, W., Zhang, J., Cho, H., Mamo, S., Bremer, R., Gillette, S., Kong, J., Haass, N. K., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711741105 · Cited by 1,346
Knowledge-based scoring function to predict protein-ligand interactions
Gohlke, H., Hendlich, M., & Klebe, G. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3371 · Cited by 1,157
Garnett, M. J., & Marais, R. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.022 · Cited by 799
Binda, C., Wang, J., Pisani, L., Caccia, C., Carotti, A., Salvati, P., Edmondson, D. E., & Mattevi, A. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070677y · Cited by 607
Comparative evaluation of eight docking tools for docking and virtual screening accuracy
Kellenberger, E., Rodrigo, J., Muller, P., & Rognan, D. (2004) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.20149 · Cited by 577
De Colibus, L., Li, M., Binda, C., Lustig, A., Edmondson, D. E., & Mattevi, A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505975102 · Cited by 527
Raf proteins and cancer: B-Raf is identified as a mutational target
Mercer, K. E., & Pritchard, C. A. (2003) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(03)00016-7 · Cited by 457
Binda, C., Li, M., Hubálek, F., Restelli, N., Edmondson, D. E., & Mattevi, A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1633804100 · Cited by 397
Roll: a new algorithm for the detection of protein pockets and cavities with a rolling probe sphere
Yu, J., Zhou, Y., Tanaka, I., & Yao, M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp599 · Cited by 397
Erickson, J. A., Jalaie, M., Robertson, D. H., Lewis, R. A., & Vieth, M. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030209y · Cited by 394
RAF inhibitors that evade paradoxical MAPK pathway activation
Zhang, C., Spevak, W., Zhang, Y., Burton, E. A., Ma, Y., Habets, G., Zhang, J., Lin, J., Ewing, T., Matusow, B., et al. (2015) · Nature · doi:10.1038/nature14982 · Cited by 382
Xiao, Z., & Théroux, P. (1998) · Circulation · doi:10.1161/01.cir.97.3.251 · Cited by 382
Latest developments in molecular docking: 2010–2011 in review
Yuriev, E., & Ramsland, P. A. (2013) · Journal of Molecular Recognition · doi:10.1002/jmr.2266 · Cited by 344
Blood Coagulation: Hemostasis and Thrombin Regulation
Tanaka, K. A., Key, N. S., & Levy, J. H. (2009) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e31819bcc9c · Cited by 342
Structure-Based Drug Design: Docking and Scoring
Kroemer, R. T. (2007) · Current Protein & Peptide Science · doi:10.2174/138920307781369382 · Cited by 342
Docking Challenge: Protein Sampling and Molecular Docking Performance
Elokely, K. M., & Doerksen, R. J. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci400040d · Cited by 287
King, A. J., Patrick, D. R., Batorsky, R. S., Ho, M. L., Do, H. T., Zhang, S. Y., Kumar, R., Rusnak, D. W., Takle, A. K., Wilson, D. M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2554 · Cited by 257
Deciphering common failures in molecular docking of ligand-protein complexes
Verkhivker, G. M., Bouzida, D., Gehlhaar, D. K., Rejto, P. A., Arthurs, S., Colson, A. B., Freer, S. T., Larson, V., Luty, B. A., Marrone, T., et al. (2000) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1008158231558 · Cited by 240
MAO-inhibitors in Parkinson's Disease
Riederer, P., & Laux, G. (2011) · Experimental Neurobiology · doi:10.5607/en.2011.20.1.1 · Cited by 215
Binda, C., Hubálek, F., Li, M., Herzig, Y., Sterling, J., Edmondson, D. E., & Mattevi, A. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm031087c · Cited by 214
Monoamine oxidases (MAO) in the pathogenesis of heart failure and ischemia/reperfusion injury
Kaludercic, N., Carpi, A., Menabò, R., Di Lisa, F., & Paolocci, N. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.09.010 · Cited by 193
Ramírez, D., & Caballero, J. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040525 · Cited by 183
Self-citationLessons in Molecular Recognition. 2. Assessing and Improving Cross-Docking Accuracy
Sutherland, J. J., Nandigam, R. K., Erickson, J. A., & Vieth, M. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci700253h · Cited by 127
Okaniwa, M., Hirose, M., Arita, T., Yabuki, M., Nakamura, A., Takagi, T., Kawamoto, T., Uchiyama, N., Sumita, A., Tsutsumi, S., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400778d · Cited by 112
Mena‐Ulecia, K., Tiznado, W., & Caballero, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142774 · Cited by 111
Self-citationStructure-Based Design of Potent Aromatase Inhibitors by High-Throughput Docking
Caporuscio, F., Rastelli, G., Imbriano, C., & Río, A. D. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2000689 · Cited by 101
Waizenegger, I. C., Baum, A., Steurer, S., Stadtmüller, H., Bader, G., Schaaf, O., Garin‐Chesa, P., Schlattl, A., Schweifer, N., Haslinger, C., et al. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0617 · Cited by 101
Molecular Insights into Human Monoamine Oxidase B Inhibition by the Glitazone Antidiabetes Drugs
Binda, C., Aldeco, M., Geldenhuys, W. J., Tortorici, M., Mattevi, A., & Edmondson, D. E. (2011) · ACS Medicinal Chemistry Letters · doi:10.1021/ml200196p · Cited by 100
Biela, A., Sielaff, F., Terwesten, F., Heine, A., Steinmetzer, T., & Klebe, G. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300337q · Cited by 90
Osguthorpe, D. J., Sherman, W., & Hagler, A. T. (2012) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2012.01396.x · Cited by 75
Hirudins: Antithrombin Anticoagulants
Stringer, K. A., & Lindenfeld, J. M. (1992) · Annals of Pharmacotherapy · doi:10.1177/106002809202601211 · Cited by 75
Identification of a Novel Family of BRAFV600E Inhibitors
Qin, J., Xie, P., Christian, V., Zhou, G., Vultur, A., Chen, Q., Liu, Q., Herlyn, M., Winkler, J. D., & Marmorstein, R. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3004416 · Cited by 75
Barreca, M. L., Iraci, N., Luca, L. D., & Chimirri, A. (2009) · ChemMedChem · doi:10.1002/cmdc.200900166 · Cited by 70
Computational Methods Applied to Rational Drug Design
Ramírez, D. (2016) · The Open Medicinal Chemistry Journal · doi:10.2174/1874104501610010007 · Cited by 68
Self-citationBallante, F., & Marshall, G. R. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00603 · Cited by 65
Alzate‐Morales, J. H., Caballero, J., Vergara‐Jaque, A., & González-Nilo, F. D. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci8004034 · Cited by 59
Self-citationB-Raf kinase inhibitors for cancer treatment.
Li, N., Batt, D. B., & Warmuth, M. (2007) · PubMed · Cited by 57
Impact of Ligand and Protein Desolvation on Ligand Binding to the S1 Pocket of Thrombin
Biela, A., Khayat, M. T. A., Tan, H., Kong, J., Heine, A., Hangauer, D. G., & Klebe, G. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.01.054 · Cited by 53
Structural and Mechanistic Studies of Mofegiline Inhibition of Recombinant Human Monoamine Oxidase B
Milczek, E. M., Bonivento, D., Binda, C., Mattevi, A., McDonald, I. A., & Edmondson, D. E. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8011867 · Cited by 50
Quesada‐Romero, L., Mena‐Ulecia, K., Tiznado, W., & Caballero, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102212 · Cited by 37
Self-citationCaballero, J., Quiliano, M., Alzate‐Morales, J. H., Zimic, M., & Deharo, E. (2011) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-011-9425-1 · Cited by 29
Self-citationNon-oxime inhibitors of B-RafV600E kinase
Ren, L. M., Wenglowsky, S., Miknis, G., Rast, B., Buckmelter, A. J., Ely, R. J., Schlachter, S. T., Laird, E. R., Randolph, N., Callejo, M., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.12.061 · Cited by 29
Caballero, J., Vergara‐Jaque, A., Fernández, M., & Coll, D. (2009) · Molecular Diversity · doi:10.1007/s11030-009-9140-1 · Cited by 26
Self-citation
Cited by
Improving Protein-Ligand Docking Results with High-Throughput Molecular Dynamics Simulations
Guterres, H., & Im, W. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00057 · Cited by 355
Molecular Docking: Principles, Advances, and Its Applications in Drug Discovery
Muhammed, M. T., & Aki-Yalcin, E. (2024) · Letters in Drug Design & Discovery · doi:10.2174/1570180819666220922103109 · Cited by 267
A new paradigm for applying deep learning to protein–ligand interaction prediction
Wang, Z., Wang, S., Li, Y., Guo, J., Wei, Y., Mu, Y., Zheng, L., & Li, W. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae145 · Cited by 41
(2024) · doi:10.1007/s00203-024-04140-y · Cited by 2
Metadata
- Authors
- Ramírez, D., & Caballero, J.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2018-04-28
- Volume
- 23
- Issue
- 5
- Pages
- 1038
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W2800892557
- Cited by
- 624
- References
- 54
- FWCI
- 18.82
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.